Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-064476
Filing Date
2009-03-26
Accepted
2009-03-26 17:26:01
Documents
7
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 881021
2 SUBSIDIARIES OF CARDIUM THERAPEUTICS, INC. dex21.htm EX-21 2199
3 CONSENT OF MARCUM & KLIEGMAN LLP dex231.htm EX-23.1 2240
4 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 6081
5 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 6097
6 SECTION 1350 CERTIFICATION dex32.htm EX-32 3512
7 GRAPHIC g97851g45k39.jpg GRAPHIC 32034
  Complete submission text file 0001193125-09-064476.txt   947157
Mailing Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 (858) 436-1000
Cardium Therapeutics, Inc. (Filer) CIK: 0000772320 (see all company filings)

EIN.: 840635673 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33635 | Film No.: 09707437
SIC: 2836 Biological Products, (No Diagnostic Substances)